I4. New vaccines
Poster Session: New Vaccines
Matthew Davis, M.D.
Medical Director
Rochester Clinical Research
Rochester, New York, United States
William Towner, MD
Division Director, Clinical Trial Research
Kaiser Permanente Southern California
Pasadena, California, United States
Elliot N. DeHaan, MD (he/him/his)
Director
Pfizer
Pearly River, New York, United States
Qin Jiang, PhD
Senior Director
Pfizer
Collegeville, Pennsylvania, United States
Wen Li, PhD
Pfizer Vaccine Clinical Research
Collegeville, Pennsylvania, United States
Farah Rahman, DO
Associate Director
Pfizer
New York, New York, United States
Michael Patton, B.Sc.
Pfizer, Vaccine Research and Development
Hurley, England, United Kingdom
Hayley Wyper, BBiomedSc
Pfizer, Inc. Vaccine Research & Development
Marlow, England, United Kingdom
Maria Maddalena Lino, PhD
Pfizer
Siena, Toscana, Italy
Uzma N. Sarwar, MD
Medical Monitor
Pfizer
Pearl River, New York, United States
Zaynah Majid-Mahomed, PharmD
Senior Manager, Clinical Scientist
Pfizer
Iselin, New Jersey, United States
Saumil Mehta, MD
AIM Trials
Plano, Texas, United States
William Howitt, MD
QPS Missouri
Springfield, Missouri, United States
Kevin Cannon, MD
Accellacare
Wilmington, North Carolina, United States
Elena Kalinina, PhD
Director
Pfizer
Pearl River, New York, United States
David Cooper, PhD
Senior Director
Pfizer
Pearl River, New York, United States
Kena A. Swanson, Ph.D.
Vice President, Viral Vaccines
Pfizer
Pearl River, New York, United States
Annaliesa S. Anderson, PhD
SVP & CSO
Pfizer
New York, New York, United States
Alejandra C. Gurtman, M.D.
Vice President
Pfizer
Pearl River, New York, United States
Iona Munjal, MD (she/her/hers)
Executive Director
Pfizer Inc, United States